Loading...

Quanta

OTCPK:QNTA
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
QNTA
OTCPK
$81M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Quanta, Inc., an applied science company, focuses on enhancing energy levels in plant matter to increase performance within the human body. The last earnings update was 10 days ago. More info.


Add to Portfolio Compare Print
  • Quanta has significant price volatility in the past 3 months.
QNTA Share Price and Events
7 Day Returns
0%
OTCPK:QNTA
3.6%
US Healthcare Services
0.9%
US Market
1 Year Returns
-
OTCPK:QNTA
29.4%
US Healthcare Services
9.6%
US Market
QNTA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Quanta (QNTA) 0% 3% 20.5% - - -
US Healthcare Services 3.6% 6% 11.8% 29.4% 59.2% 58.5%
US Market 0.9% 4.6% 10.9% 9.6% 39% 47.2%
1 Year Return vs Industry and Market
  • No trading data on QNTA.
  • No trading data on QNTA.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

QNTA Value

 Is Quanta undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Quanta. This is due to cash flow or dividend data being unavailable. The share price is $2.06.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Quanta's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Quanta's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:QNTA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.06
OTCPK:QNTA Share Price ** OTCPK (2019-04-11) in USD $2.06
United States of America Healthcare Services Industry PE Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 81.84x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.28x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Quanta.

OTCPK:QNTA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:QNTA Share Price ÷ EPS (both in USD)

= 2.06 ÷ -0.06

-33.6x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Quanta is loss making, we can't compare its value to the US Healthcare Services industry average.
  • Quanta is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Quanta's expected growth come at a high price?
Raw Data
OTCPK:QNTA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -33.6x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Healthcare Services Industry PEG Ratio Median Figure of 13 Publicly-Listed Healthcare Services Companies 2.75x
United States of America Market PEG Ratio Median Figure of 2,113 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Quanta, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Quanta's assets?
Raw Data
OTCPK:QNTA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.01
OTCPK:QNTA Share Price * OTCPK (2019-04-11) in USD $2.06
United States of America Healthcare Services Industry PB Ratio Median Figure of 35 Publicly-Listed Healthcare Services Companies 4.33x
United States of America Market PB Ratio Median Figure of 5,185 Publicly-Listed Companies 1.92x
OTCPK:QNTA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:QNTA Share Price ÷ Book Value per Share (both in USD)

= 2.06 ÷ 0.01

316.19x

* Primary Listing of Quanta.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Quanta is overvalued based on assets compared to the US Healthcare Services industry average.
X
Value checks
We assess Quanta's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Quanta has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

QNTA Future Performance

 How is Quanta expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Quanta has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
22.8%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Quanta expected to grow at an attractive rate?
  • Unable to compare Quanta's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Quanta's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Quanta's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:QNTA Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 22.8%
United States of America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 11.5%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.5%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:QNTA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:QNTA Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 0 -1 -2
2018-03-31 0 -1 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Quanta is high growth as no earnings estimate data is available.
  • Unable to determine if Quanta is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:QNTA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Quanta Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:QNTA Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.06
2018-03-31 -0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Quanta will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of QNTA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Quanta's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Quanta's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Quanta's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Quanta has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

QNTA Past Performance

  How has Quanta performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Quanta's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Quanta does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Quanta's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Quanta's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Quanta's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Quanta Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:QNTA Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 0.30 -2.15 2.01 0.28
2018-03-31 0.05 -0.74 0.48 0.21

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Quanta has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Quanta has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Quanta improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Quanta's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Quanta has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

QNTA Health

 How is Quanta's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Quanta's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Quanta's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Quanta has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Quanta's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Quanta Company Filings, last reported 3 months ago.

OTCPK:QNTA Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 0.26 0.18 0.04
2018-03-31 -0.83 1.14 0.05
  • Quanta's level of debt (70.5%) compared to net worth is high (greater than 40%).
  • Unable to establish if Quanta's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Quanta has less than a year of cash runway based on current free cash flow.
  • Quanta has less than a year of cash runway if free cash flow continues to grow at historical rates of 91.3% each year.
X
Financial health checks
We assess Quanta's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Quanta has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

QNTA Dividends

 What is Quanta's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Quanta dividends.
If you bought $2,000 of Quanta shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Quanta's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Quanta's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:QNTA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 15 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2008 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Quanta has not reported any payouts.
  • Unable to verify if Quanta's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Quanta's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Quanta has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Quanta's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Quanta afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Quanta has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

QNTA Management

 What is the CEO of Quanta's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Eric Rice
COMPENSATION $0
AGE 41
TENURE AS CEO 0.8 years
CEO Bio

Mr. Eric Rice is the Founder of Quanta Inc. in 2016 and serves as its Chief Executive Officer since June 6, 2018 and its Chairman and Chief Financial Officer. Prior to founding Quanta in 2016, Mr. Rice founded several successful technology companies and was a pioneer in the digital media sector. He has built several companies in numerous verticals including financial services, digital media, artificial intelligence, biotechnology, live gaming and cannabis. Mr. Rice leads Quanta’s operations and overall strategic direction. He holds a Bachelor of Arts Degree in SCS from Indiana University. Mr. Rice’s status as the founder along with his extensive experience in marketing led to the conclusion that he is qualified to serve in these capacities.

CEO Compensation
  • Insufficient data for Eric to compare compensation growth.
  • Eric's remuneration is lower than average for companies of similar size in United States of America.
Management Team

Eric Rice

TITLE
Founder
AGE
41
TENURE
0.8 yrs

Jeffrey Doiron

TITLE
President & COO
AGE
45
Board of Directors

Eric Rice

TITLE
Founder
AGE
41
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Quanta's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Quanta has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

QNTA News

Simply Wall St News

QNTA Company Info

Description

Quanta, Inc., an applied science company, focuses on enhancing energy levels in plant matter to increase performance within the human body. Its proprietary technology uses quantum mechanics to increase bio-activity of targeted molecules to enhance the desired effects. The company specializes in potentiating rare naturally occurring elements to create impactful and sustainable healing solutions that are as pharmaceutical drugs. It offers its technology as a platform to product makers through distribution channels, as well as consumer products. The company serves brands in cannabis, anti-aging, health and wellness, stress management, pain management, fitness, and brain performance enhancement. The company was founded in 2016 and is headquartered in Los Angeles, California.

Details
Name: Quanta, Inc.
QNTA
Exchange: OTCPK
Founded: 2016
$80,752,185
39,200,090
Website: http://
Address: Quanta, Inc.
110 East 9th Street,
12B,
Los Angeles,
California, 90079,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK QNTA New Common Stock Pink Sheets LLC US USD 07. Jun 2018
Number of employees
Current staff
Staff numbers
14
Quanta employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/26 03:28
End of day share price update: 2019/04/11 00:00
Last earnings filing: 2019/04/16
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.